Literature DB >> 21346320

Characterization of the brain β-amyloid isoform pattern at different ages of Tg2576 mice.

Tamanna Mustafiz1, Erik Portelius, Mikael K Gustavsson, Mikko Hölttä, Henrik Zetterberg, Kaj Blennow, Agneta Nordberg, Christina Unger Lithner.   

Abstract

BACKGROUND: Although genetic and biochemical studies have suggested a cardinal role for β-amyloid (Aβ) in Alzheimer's disease, the underlying mechanism(s) of how Aβ induces neurodegeneration is still unclear. Our objective was to investigate the consequences of Aβ, especially on tau phosphorylation at specific epitopes important for Alzheimer's disease.
METHODS: We used cortices from Tg2576 mice at 7 days to 15 months of age.
RESULTS: MALDI-TOF MS revealed an age-dependent shift in the Aβ isoform pattern. Young animals displayed high cortical levels of the shorter Aβ isoforms (Aβ1-16 and Aβ1-17) compared to 15-month-old Tg2576 mice which mainly expressed Aβ1-40 and Aβ1-42. The Aβ1-42 showed an age-dependent increase, whereas total Aβ1-40 levels remained constant. The highest levels of TBS-soluble Aβ oligomers were found at 90 days of age. Brain Aβ build-up did not affect the phosphorylation of tau at the epitopes investigated.
CONCLUSIONS: This study provides new information about age-dependent Aβ isoforms and oligomers as well as their effect on site-specific tau phosphorylation in this transgenic mouse model. Our observations suggest that the different human Aβ isoforms do not directly cause increased tau phosphorylation and that the cognitive deficits seen in this mouse model are only related to the Aβ overexpression.
Copyright © 2011 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21346320     DOI: 10.1159/000323871

Source DB:  PubMed          Journal:  Neurodegener Dis        ISSN: 1660-2854            Impact factor:   2.977


  9 in total

1.  Early impairment of long-term depression in the perirhinal cortex of a mouse model of Alzheimer's disease.

Authors:  Francesco Tamagnini; Costanza Burattini; Tiziana Casoli; Marta Balietti; Patrizia Fattoretti; Giorgio Aicardi
Journal:  Rejuvenation Res       Date:  2012-04       Impact factor: 4.663

2.  Subchronic glucocorticoid receptor inhibition rescues early episodic memory and synaptic plasticity deficits in a mouse model of Alzheimer's disease.

Authors:  Fabien Lanté; Magda Chafai; Elisabeth Fabienne Raymond; Ana Rita Salgueiro Pereira; Xavier Mouska; Scherazad Kootar; Jacques Barik; Ingrid Bethus; Hélène Marie
Journal:  Neuropsychopharmacology       Date:  2015-01-27       Impact factor: 7.853

3.  Vaccine Development to Treat Alzheimer's Disease Neuropathology in APP/PS1 Transgenic Mice.

Authors:  Iván Carrera; Ignacio Etcheverría; Lucía Fernández-Novoa; Valter Lombardi; Ramón Cacabelos; Carmen Vigo
Journal:  Int J Alzheimers Dis       Date:  2012-09-16

4.  Evaluating amyloid-β oligomers in cerebrospinal fluid as a biomarker for Alzheimer's disease.

Authors:  Mikko Hölttä; Oskar Hansson; Ulf Andreasson; Joakim Hertze; Lennart Minthon; Katarina Nägga; Niels Andreasen; Henrik Zetterberg; Kaj Blennow
Journal:  PLoS One       Date:  2013-06-14       Impact factor: 3.240

5.  Small-animal PET imaging of amyloid-beta plaques with [11C]PiB and its multi-modal validation in an APP/PS1 mouse model of Alzheimer's disease.

Authors:  André Manook; Behrooz H Yousefi; Antje Willuweit; Stefan Platzer; Sybille Reder; Andreas Voss; Marc Huisman; Markus Settles; Frauke Neff; Joachim Velden; Michael Schoor; Heinz von der Kammer; Hans-Jürgen Wester; Markus Schwaiger; Gjermund Henriksen; Alexander Drzezga
Journal:  PLoS One       Date:  2012-03-09       Impact factor: 3.240

6.  Astrocytosis precedes amyloid plaque deposition in Alzheimer APPswe transgenic mouse brain: a correlative positron emission tomography and in vitro imaging study.

Authors:  Elena Rodriguez-Vieitez; Ruiqing Ni; Balázs Gulyás; Miklós Tóth; Jenny Häggkvist; Christer Halldin; Larysa Voytenko; Amelia Marutle; Agneta Nordberg
Journal:  Eur J Nucl Med Mol Imaging       Date:  2015-04-17       Impact factor: 9.236

7.  Trisomy of human chromosome 21 enhances amyloid-β deposition independently of an extra copy of APP.

Authors:  Frances K Wiseman; Laura J Pulford; Chris Barkus; Fan Liao; Erik Portelius; Robin Webb; Lucia Chávez-Gutiérrez; Karen Cleverley; Sue Noy; Olivia Sheppard; Toby Collins; Caroline Powell; Claire J Sarell; Matthew Rickman; Xun Choong; Justin L Tosh; Carlos Siganporia; Heather T Whittaker; Floy Stewart; Maria Szaruga; Michael P Murphy; Kaj Blennow; Bart de Strooper; Henrik Zetterberg; David Bannerman; David M Holtzman; Victor L J Tybulewicz; Elizabeth M C Fisher
Journal:  Brain       Date:  2018-08-01       Impact factor: 13.501

8.  Neural Stem Cell Transplant-Induced Effect on Neurogenesis and Cognition in Alzheimer Tg2576 Mice Is Inhibited by Concomitant Treatment with Amyloid-Lowering or Cholinergic α7 Nicotinic Receptor Drugs.

Authors:  Anna M Lilja; Linn Malmsten; Jennie Röjdner; Larysa Voytenko; Alexei Verkhratsky; Sven Ove Ögren; Agneta Nordberg; Amelia Marutle
Journal:  Neural Plast       Date:  2015-07-15       Impact factor: 3.599

9.  Outstanding Phenotypic Differences in the Profile of Amyloid-β between Tg2576 and APPswe/PS1dE9 Transgenic Mouse Models of Alzheimer's Disease.

Authors:  José Antonio Allué; Leticia Sarasa; María Izco; Virginia Pérez-Grijalba; Noelia Fandos; María Pascual-Lucas; Samuel Ogueta; Pedro Pesini; Manuel Sarasa
Journal:  J Alzheimers Dis       Date:  2016-05-30       Impact factor: 4.472

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.